Gujarat Themis Biosyn Limited Receivables

The latest receivables for GUJTHEM.BO is $610M as of March 2026. That compares with $310M in the prior-year period — up 93.7% year over year. Investors often review this figure alongside Gujarat Themis Biosyn Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, GUJTHEM.BO's receivables moved from $310M to $610M — a 93.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Gujarat Themis Biosyn Limited's operating scale or balance-sheet position.

A receivables figure of $610M for GUJTHEM.BO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GUJTHEM.BO's receivables ($610M), review year-over-year change from $310M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.